Genestack
Genestack builds the Open Data Manager (ODM), an open platform for managing and integrating multi-omics data for pharmaceutical R&D, agricultural science, and academic life science research organizations, deployed on customer cloud or on-premises infrastructure.
- Company typePrivate
- Founded2011
- HeadquartersCambridge, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Genestack does
Genestack is a Cambridge, UK-headquartered software company founded in 2011 that builds the Open Data Manager (ODM), an open platform for managing and integrating multi-omics and other life science data. ODM transforms fragmented genomics, transcriptomics, proteomics, metabolomics, radiomics, and EEG data into governed, queryable analytical assets aligned with FAIR (Findable, Accessible, Interoperable, Reusable) principles and the company's extension of FAIR+T (Trustworthy) for lineage, quality, and accountability. The platform is delivered as a platform-plus-modules architecture comprising Data Asset Registry, Curation Tools, Analytical Search (REST API with Python/R SDKs), Integration, Security & Compliance, and ODM Intelligence (AI-native curation, agentic analytics, MCP server). Deployment options include customer cloud, on-premises, or Genestack-managed cloud.
Genestack serves pharmaceutical R&D (AstraZeneca, UCB), agricultural science (Bayer Crop Science, Corteva, Bejo), consumer goods (Unilever), and academic and public-sector research (Wellcome Sanger Institute, CUNY, University of Colorado, University of Trento, Bioconductor). The company operates an enterprise field sales motion with consultative deployment, supported by content marketing, industry conferences (Bio-IT World), and ecosystem partnerships including the Pistoia Alliance and CUNY. The company maintains a distributed global team across the UK, US, Germany, Spain, and Serbia (the latter as an engineering and group services affiliate).
Revenue is generated primarily through annual subscription licensing of the ODM platform, supplemented by professional services for implementation, ontology planning, and FAIRification. Pricing is quote-based with no publicly disclosed tiers, consistent with enterprise SaaS. The company holds ISO/IEC 27001:2022 certification and has aligned ODM with FDA 21 CFR Part 11 and ICH E6(R2) regulatory frameworks, positioning it for regulated pharma R&D procurement. No venture funding rounds have been disclosed, and the company is privately held with founder and CEO Misha Kapushesky leading a 51–100 person organization.
Genestack firmographics
Firmographics- Name
- Genestack
- Legal name
- Genestack Limited
- Website
- https://genestack.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Genestack builds the Open Data Manager (ODM), an open platform for managing and integrating multi-omics data for pharmaceutical R&D, agricultural science, and academic life science research organizations, deployed on customer cloud or on-premises infrastructure.
- Ownership category
- akta.pro rank
Genestack industry classification
Industry- Product category
- Life Sciences Data Management Software
- NAICS
- Software Publishers (5132), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
- akta.pro secondary industries
- Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)
Keywords
Where Genestack is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices6 records
Markets served
Genestack business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- Software Platform Licensing: The primary revenue stream is from licensing the Open Data Manager platform. Organizations deploy ODM on their cloud infrastructure, on-premises, or through Genestack's managed cloud. The platform serves as the data intelligence layer for FAIR, AI-ready R&D.
- Professional Services: Implementation, training, and consulting services to help customers deploy and optimize their data management workflows. Genestack works with customers on ontology planning, metadata modeling, and FAIRification processes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise platform licensing with custom deployment options |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Genestack product offering
Product offeringCore offering
Genestack sells the Open Data Manager (ODM), an enterprise software platform that turns multimodal life science data (genomics, transcriptomics, proteomics, metabolomics, radiomics, EEG) into a governed, queryable analytical asset. The platform is sold via annual subscription licensing to pharmaceutical, biotech, agricultural, and academic research organizations, with deployment on customer cloud, on-premises, or Genestack-managed cloud environments, and is supplemented by professional services for implementation and FAIRification.
Product overview
Genestack offers the Open Data Manager (ODM), an open platform that transforms multimodal life science data into a governed, queryable analytical asset. The platform follows a platform-plus-modules architecture centered on ODM, with specialized modules including Analytical Search (for large-scale cross-study queries via REST APIs), Data Asset Registry/Data Catalog (for structured visibility across studies and samples), Curation Tools (for metadata harmonization with ontologies and templates), Integration Module (for seamless IT architecture connectivity), Security & Compliance Module (for regulatory frameworks including 21 CFR Part 11 and ISO 27002), and ODM Intelligence (AI-ready layer featuring LLM-powered curation, agentic analytics, and MCP server for AI platform integration). Services are available to support implementation.
Differentiator
Problem solved
Functional benefit
Brands
- Open Data Manager (ODM): An open platform that turns multimodal life science data into a governed, queryable analytical asset for FAIR, AI-Ready R&D
- ODM Intelligence
- Analytical Search
- Curation Tools
- Data Asset Registry
Products and services
- Open Data Manager (ODM)
Quantifiable outcome
- Reduces data cleaning time from 2 hours per dataset to under 1 hour for all datasets combined
- +2 more outcomes
Companies that use Genestack
Customer profileNamed customers11 records
Segments3 records
Ideal customer profiles3 records
Genestack technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability5 records
Feature7 records
Genestack partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and supporting.
- City University of New York (CUNY) - Dr. Sehyun OhcoreCollaboration to make public omics data FAIR and AI-ready using ODM and OmicsMLRepoR package. Joint presentation at Bio-IT 2025 World Conference. Combined Genestack's ontology-driven templates and automated harmonization workflows with CUNY's OmicsMLRepoR project for metadata harmonization and ontology alignment.
- Pistoia AlliancecoreGenestack joined the Pistoia Alliance, a global, not-for-profit, pre-competitive alliance of life sciences organizations. The alliance focuses on making R&D more efficient through collaboration on data standards, workflows, and emerging technologies including AI/ML and FAIR data principles.
- Amazon Web Services (AWS)coreAWS is used to host Genestack's products and certain operational systems, providing cloud infrastructure for ODM deployments.
- SalesforcesupportingSalesforce is used for CRM and form tracking, enabling customer relationship management and website interaction tracking.
- Google (Google Analytics 4)supportingGoogle Analytics 4 is used to understand website performance and user experience, activated only with analytics consent.
- LinkedInsupportingLinkedIn Insight Tag is used for advertising measurement and audience building, activated only with marketing consent.
- EnzuzosupportingEnzuzo Inc. operates the cookie consent management platform on the Genestack website.
- HotjarsupportingHotjar is used to understand website performance and user experience, activated only with analytics consent.
Scale indicators2 records
Recent moves5 records
Expansion highlights6 records
Genestack competitors and assessment
Company assessmentDirect peers
- DNAnexus: Provides a cloud-based biomedical data analysis and management platform for genomics and multi-omics R&D. Directly competes with Genestack's ODM for enterprise pharma and clinical genomics customers.
- Genedata: Enterprise software for biopharma R&D data management, including screening, omics, and biologics workflows. Closely comparable to Genestack's enterprise life sciences data management positioning.
- Velsera (formerly Seven Bridges): Bioinformatics and multi-omics analysis platform serving pharma, clinical research, and consortia. Competes with Genestack on cross-study omics querying and FAIR data infrastructure.
- TetraScience: Cloud-native R&D data platform for life sciences with AI-ready data lake architecture. Adjacent competitor in life sciences R&D data management, with broader scientific scope beyond omics.
- BC Platforms: Genomics and life sciences data management platform serving pharma, biobanks, and healthcare systems. Directly comparable to Genestack on multi-omics data integration and access.
- Paradigm4: Scientific data management platform (REVEAL) for multi-modal life sciences data, including omics and clinical data. Comparable to Genestack on cross-study querying and analytical scale.
- Sapio Sciences: Lab informatics platform spanning LIMS, ELN, and scientific data management for life sciences R&D. Overlaps with Genestack on enterprise life sciences data infrastructure.
Broad incumbents
- Illumina (Connected Software / BaseSpace Sequence Hub): Dominant sequencing platform with growing multi-omics informatics portfolio. Incumbent threat through bundling of sequencing hardware with data management and analysis software.
- AWS HealthOmics: Amazon's managed genomics and multi-omics storage, workflow, and analytics service. Hyperscaler incumbent that competes on cloud-native omics infrastructure at scale.
- Databricks (Life Sciences / BioSpark): Unified data and AI platform with growing life sciences practice. Increasingly competes for multi-omics data lake and AI/ML workloads that Genestack addresses with ODM Intelligence.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Genestack social profiles
Digital presenceGenestack compliance and trust
Trust signalCompliance3 records
Genestack financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genestack leadership team
Management profileNumber of profiles
Profiles2 records
Genestack subsidiaries and ownership
Company hierarchySubsidiaries1 record
Genestack funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genestack M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genestack
What does Genestack do?
Genestack sells the Open Data Manager (ODM), an enterprise software platform that turns multimodal life science data (genomics, transcriptomics, proteomics, metabolomics, radiomics, EEG) into a governed, queryable analytical asset. The platform is sold via annual subscription licensing to pharmaceutical, biotech, agricultural, and academic research organizations, with deployment on customer cloud, on-premises, or Genestack-managed cloud environments, and is supplemented by professional services for implementation and FAIRification.
Is Genestack a public or private company?
Genestack is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Genestack founded?
Genestack was founded in 2011. It employs 51 to 100 people.
Where is Genestack based?
Genestack is headquartered in Cambridge, United Kingdom, in the Europe region.
How does Genestack make money?
Two revenue lines are on record. Software Platform Licensing is the primary driver. The others are professional Services.
Who are Genestack's main competitors?
Direct peers on record are DNAnexus, Genedata, Velsera (formerly Seven Bridges), TetraScience, BC Platforms, Paradigm4 and Sapio Sciences. Broad incumbents are Illumina (Connected Software / BaseSpace Sequence Hub), AWS HealthOmics and Databricks (Life Sciences / BioSpark).
Does Genestack have an API?
Yes. Perform large-scale, cross-study, and integrative queries across Life Science Data via well-documented REST APIs. The API enables programmatic loading, selection, and analysis of data, including Python and R packages for seamless integration with Jupyter notebooks, R-Shiny, and custom analytics pipelines. Data can be queried based on metadata, with results sent directly to AI workflows.
What industry is Genestack in?
Genestack's product category is Life Sciences Data Management Software. Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services, with a secondary code of HLAAAMAJ, Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics). Its NAICS code is 5132 and its SIC code is 7372.